Search | Page 2 | ASTRO

Radiobiology-guided Innovations in the Integration of Radiation & Immunotherapies
Pushing the Boundaries: Re-Irradiation for Pediatric Brain Tumors
Cancer Stem Cells (CSC) and Radiation Response: Current Views and Future Perspectives in Radiation Oncology
Combined Modality Therapy for Lymph Node Positive Prostate Cancer
Innovative Radiation Therapy Approaches: Benefits & Challenges - Global Perspective
Update on ASTRO's Partial Breast Irradiation Guidelines: Case-based Discussion
Pitfalls, Perils and Pearls: Identifying and Managing Gynecologic Treatment Toxicity
How Sentinel Lymph Node Biopsy is Impacting Adjuvant Radiation Treatment in Gynecologic Cancers
Hypofractionation for Soft Tissue Sarcoma
Beyond Counting on Our Fingers: The Current State and Future Management of Oligometastatic Lung Cancer
At the Cutting Edge: The Increasing Role of Salvage Radiotherapy in Relapsed/Refractory Lymphomas
Is Consolidation Radiotherapy Still Needed for Lymphoma in 2024? Reappraisal in Light of Recent Trials Results
Practical Elements of a Radiopharmaceutical Program: Findings from ASTRO's Safety White Paper
Decoding Radiation Oncology - Parts 1 and 2
Developing as an Early Career Physician
Prophylactic Feeding Tube Placement in Head and Neck Cancer: Hard to Swallow?
Geriatric Radiation Oncology: Partnering With and Personalizing Cancer Care for Older Adults
Getting Your Ducks in a Row: Experiences Operationalizing Adaptive Radiotherapy
Navigating Medical Insurance Delays and Denials: Insights from Patients, ASTRO and the Press
Head and Neck Cancer - Prevention and Management of Radiation Therapy Toxicity in the Community Setting
Best Practices in the Management of Oligometastatic and Oligoprogressive Liver Metastases
Emerging Diagnostic and Therapeutic Options for Meningioma
ASTRO/JASTRO Joint Session: Advances in Liver Cancer Radiation Therapy
Advances in Breast Cancer Management: Early-Stage Disease, Post-Neoadjuvant Radiation Therapy and IMRT for Breast Cancer Treatment in a Community Setting
Management of Unfavorable Intermediate-Risk Prostate Cancer: Role of SBRT, Brachytherapy and Androgen Deprivation

Pages